Table: Kyorin Pharmaceutical -2022/23 parent results

Kyorin Pharmaceutical

11/05/2023 07:00

May 11 (Reuters)- 
          Kyorin Pharmaceutical Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales                                         100.00        45.90    
  Revenues        5.85            6.58                                 
               (-11.0 pct)     (-8.5 pct)                              
  Operating       3.06            4.05            6.10         1.30    
               (-24.4 pct)     (-13.6 pct)    (+99.3 pct)  (-32.7 pct) 
  Recurring       2.98            3.96            6.80         1.70    
               (-24.9 pct)     (-13.6 pct)   (+128.5 pct)  (-10.1 pct) 
  Net             3.01            3.92           50.90        47.00    
               (-23.3 pct)     (-13.2 pct)                             
  EPS           51.78 yen       67.51 yen     888.14 yen    820.09 yen 
  Ann Div       52.00 yen       52.00 yen      52.00 yen               
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen               
  -Q4 Div       32.00 yen       32.00 yen      32.00 yen               
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T